Fig. 1From: Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective studyRate of progression-free survival and overall survival among patients with ocular adnexal lymphoma who was treated with ultra-low-dose radiotherapy (n = 16)Back to article page